Growing adoption of genomics fueling the DNA synthesis technology market

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Enzymatic Deoxyribonucleic Acid (DNA) Synthesis Technology Market Expected To Change Between 2026 And 2030?

The market size for enzymatic deoxyribonucleic acid (dna) synthesis technology has expanded significantly in recent years. It is forecast to grow from $3.05 billion in 2025 to $3.77 billion in 2026, achieving a compound annual growth rate (CAGR) of 23.3%. The growth observed in the past can be attributed to the rising adoption of synthetic biology in research, the inherent limitations of chemical dna synthesis methods, developments in genomics and gene editing research, an increase in biotech research funding, and the greater availability of enzyme engineering technologies.

The enzymatic deoxyribonucleic acid (dna) synthesis technology market is anticipated to experience substantial growth over the coming years. This market is projected to reach $8.77 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 23.5%. The expansion during the forecast period is driven by factors such as the increasing need for scalable DNA manufacturing, a rising acceptance of DNA-based data storage concepts, the broadening of biopharmaceutical development pipelines, growing investments in sustainable biotech processes, and the increased adoption of automated and microfluidic synthesis systems. Key trends for this period include the wider implementation of enzymatic DNA synthesis platforms, an escalating demand for long and high-fidelity DNA constructs, the proliferation of benchtop and cloud-based synthesis models, a heightened focus on environmentally sustainable DNA manufacturing, and improved integration with synthetic biology workflows.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33107&type=smp

Which Market Drivers Are Supporting The Expansion Of The Enzymatic Deoxyribonucleic Acid (DNA) Synthesis Technology Market?

The expanding embrace of genomics and personalized medicine is anticipated to drive the advancement of the enzymatic DNA synthesis technology market in the future. Genomics and personalized medicine involve leveraging genetic data and precise healthcare methods to customize diagnostic tools, therapeutic interventions, and preventative measures for specific genetic blueprints. The increased uptake of genomics and personalized medicine stems from ongoing progress in sequencing technologies, which has resulted in reduced expenses and quicker analysis periods, contributing to improved clinical results and enhanced care effectiveness. Enzymatic DNA synthesis technology facilitates genomics and personalized medicine through its capacity for scalable, high-accuracy DNA production, which is crucial for manufacturing tailored genetic sequences and devising specific therapies. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that the Food and Drug Administration sanctioned 16 novel personalized treatments for rare conditions in 2023, marking a significant rise from the 6 approvals observed in 2022. Consequently, the growing acceptance of genomics and personalized medicine is fueling the expansion of the enzymatic DNA synthesis technology market.

How Is The Enzymatic Deoxyribonucleic Acid (DNA) Synthesis Technology Market Structured Across Different Segments?

The enzymatic deoxyribonucleic acid (dna) synthesis technology market covered in this report is segmented –

1) By Technology: Polymerase Mediated Synthesis; Terminal Deoxynucleotidyl Transferase (TdT); Template Free Ligase Based Synthesis; Hybrid Chemical Enzymatic Workflows; Xeno Nucleic Acid (XNA) Synthesis Platforms

2) By Fragment: Short Oligos; Gene Fragments; Long Constructs

3) By Delivery Model: Benchtop Instrument; Outsourced Service; Cloud Based As A Service

4) By Application: Synthetic Biology; Genomics And Gene Editing; Biopharmaceutical Development; Diagnostics And Research Tools; Biotechnology Research And Development

5) By End-User Or Application: Academic And Government Research Institutes; Pharmaceutical And Biotechnology Companies; Diagnostic Companies; Agricultural Biotech Companies; Industrial Biotech And Chemical Companies

Subsegments:

1) By Polymerase Mediated Synthesis: Polymerase Chain Reaction Based Synthesis; Isothermal Amplification Based Synthesis; Rolling Circle Amplification Based Synthesis; Strand Displacement Amplification Based Synthesis; Primer Extension Based Synthesis

2) By Terminal Deoxynucleotidyl Transferase (TdT): Single Nucleotide Addition Synthesis; Homopolymer Tail Synthesis; Random Oligonucleotide Tail Synthesis; Labeling And Tagging Synthesis; Enzyme Mediated Extension Synthesis

3) By Template Free Ligase Based Synthesis: Enzymatic Ligation Synthesis; Oligonucleotide Assembly Synthesis; Fragment Ligation Synthesis; Cyclic Ligation Synthesis; Automated Ligase Synthesis

4) By Hybrid Chemical Enzymatic Workflows: Phosphoramidite Enzymatic Integration Synthesis; Chemical Precursor Enzymatic Extension Synthesis; Stepwise Hybrid Synthesis; Enzyme Assisted Chemical Assembly Synthesis; Automated Hybrid Workflow Synthesis

5) By Xeno Nucleic Acid (XNA) Synthesis Platforms: Peptide Nucleic Acid Synthesis; Locked Nucleic Acid Synthesis; Glycol Nucleic Acid Synthesis; Threose Nucleic Acid Synthesis; Cyclohexenyl Nucleic Acid Synthesis

Which Trends Are Shaping The Future Of The Enzymatic Deoxyribonucleic Acid (DNA) Synthesis Technology Market?

Major companies in the enzymatic deoxyribonucleic acid (DNA) synthesis technology market are concentrating on creating sophisticated solutions, specifically algorithm-driven enzymatic DNA synthesis platforms. These innovations aim to facilitate the creation of extended, more intricate, and highly precise synthetic DNA sequences. Algorithm-driven enzymatic DNA synthesis platforms utilize advanced computational frameworks to direct enzyme-based, sequential DNA synthesis in a laboratory setting. Such systems boost sequence accuracy, expandability, and production by continuously adjusting synthesis parameters through real-time error prediction and correction mechanisms. For example, in May 2025, Ribbon Bio, an Austria-based synthetic biology company, launched its MiroSynth DNA molecules, designed to enable a new era of complex and lengthy synthetic DNA constructs. This algorithm-powered technology allows for the construction of DNA sequences that are considerably longer and more exact than those possible with traditional techniques, thereby supporting advanced uses in gene therapy, synthetic biology, and industrial biotechnology. The solution employs specialized enzymatic processes to reduce error rates, enhance scalability, and uphold high sequence accuracy, making it ideal for stringent downstream biological applications. It is engineered to meet the increasing need for complex DNA structures while providing greater reliability, sustainability, and design adaptability compared to older DNA synthesis technologies.

Who Are The Leading Companies Operating In The Enzymatic Deoxyribonucleic Acid (DNA) Synthesis Technology Market?

Major companies operating in the enzymatic deoxyribonucleic acid (dna) synthesis technology market are Thermo Fisher Scientific Inc, Almac Group Limited, Twist Bioscience Corporation, DNA Script SAS, Synbio Technologies, Telesis Bio Inc., Touchlight Genetics Limited, Yeasen Biotechnology, CD Genomics, Bioneer Corporation, Ansa Biotechnologies Inc., Elegen Corporation, Molecular Assemblies Inc., Moligo Technologies AB, Evonetix Ltd, Camena Bioscience Limited, Baseclick GmbH, Kern Systems, Ribbon Bio, and Helixworks.

Read the full enzymatic deoxyribonucleic acid (dna) synthesis technology market report here:

https://www.thebusinessresearchcompany.com/report/enzymatic-deoxyribonucleic-acid-dna-synthesis-technology-market-report

Which Regions Are Projected To Dominate The Enzymatic Deoxyribonucleic Acid (DNA) Synthesis Technology Market In The Coming Years?

North America was the largest region in the enzymatic deoxyribonucleic acid (DNA) synthesis technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzymatic deoxyribonucleic acid (dna) synthesis technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Enzymatic Deoxyribonucleic Acid (DNA) Synthesis Technology Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=33107&type=smp

Browse Through More Reports Similar to the Global Enzymatic Deoxyribonucleic Acid (DNA) Synthesis Technology Market 2026, By The Business Research Company

Oligonucleotide Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

Recombinant Dna Technology Market Report 2026

https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report

Nucleic Acid Based Gene Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info